March 9th, 2023
Diaceutics study of US patient data shows 64% of lung cancer patients failed to receive the appropriate treatment for their needs
Ground-breaking findings have serious implications for global cancer treatment
Failure to pursue personalised treatment strategies can limit the impact of medicines and costs lives